Throwback Thursday: Second Acts in America – Was F. Scott Fitzgerald misunderstood?
When the HIV/AIDS crisis began in the 1980’s, activists pushed the FDA to speed up its drug approval process to make life-saving experimental drugs available more quickly. Now a new push is underway to improve the pace of regulatory review for new drugs and increase funding for the National Institutes of Health. One of the medical philanthropists supporting passage of the 21st Century Cures Act is the 1980’s financier and cancer survivor, Michael Milken, a man whose second act has been a quiet success.
If you need help with a forensic accounting at the end of a first act or healthcare consulting for the second, Asterion professionals can assist you.
Is there more to a negotiation than the substance of the deal?
In a December 2015 article for the Harvard Business Review, Deepak Malhotra, Harvard Professor and author of the 2011 best seller, I Moved Your Cheese, offers his latest thinking on how to avoid assumptions and costly missteps that occur before negotiations even begin.
If the deal you are negotiating requires a sophisticated financial analysis or an unshakeable valuation, add the experienced financial consultants at Asterion to your team. Then you’ll have process and substance on your side.
On the Lighter Side: Should you let science guide your gift giving this year?
Choosing holiday presents can be mystifying, especially when you’re pressed for time. Follow these seven principles--they may lead to fewer shopping mistakes.
Spotlight on Healthcare Valuation and Consulting
Asterion, Inc. (“Asterion”) has extensive experience providing consulting and valuation advice to the healthcare industry.